Disease | sclerosing cholangitis |
Comorbidity | C0023895|liver disease |
Sentences | 6 |
PubMedID- 20065573 | [18]reported (in chronic liver disease due to primary sclerosing cholangitis) platelet count of < 150000 to be predictor of ov. |
PubMedID- 26134882 | We present a 24-year-old man who developed primary cytomegalovirus peritonitis without gut perforation, but with concomitant colitis 6 weeks after liver transplant from a deceased donor for end-stage liver disease because of primary sclerosing cholangitis. |
PubMedID- 24510391 | Prevalence and relevance of nonalcoholic fatty liver disease in patients with primary sclerosing cholangitis. |
PubMedID- 24344944 | Materials and methods: in 71 patients who had a liver transplant for end-stage liver disease because of primary sclerosing cholangitis, a retrospective review was done to evaluate biliary complication-free survival, transplanted organ survival, and death. |
PubMedID- 22104752 | Progressive destruction of bile ducts in primary sclerosing cholangitis (psc) may lead to end-stage liver disease, portal hypertension and liver failure. |
PubMedID- 26438008 | Liver transplantation (lt) is the only definitive treatment for patients with end-stage liver disease due to primary sclerosing cholangitis (psc) but a high rate of biliary strictures (bs) and of recurrence (recpsc) has been reported. |
Page: 1